Med Princ Pract. 2018;27(1):23-29. doi: 10.1159/000486572. Epub 2018 Jan 3.
To explore the impact of auditory integrative training (AIT) on the inflammatory biomarker transforming growth factor (TGF)-β1 and to assess its effect on social behavior in children with autism spectrum disorder (ASD).
In this cross-sectional study, 15 patients (14 males and 1 female) with ASD aged 3-12 years were recruited. All were screened for autism using the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Plasma levels of TGF-β1 were measured in all patients using a sandwich enzyme-linked immunoassay (ELISA) immediately and 1 and 3 months after the AIT sessions. Pre- and post-AIT behavioral scores were also calculated for each child using the Childhood Autism Rating Scale (CARS), the Social Responsiveness Scale (SRS), and the Short Sensory Profile (SSP). Data were analyzed using the Statistical Package for the Social Sciences (SPSS 21.0 for Windows).
Plasma levels of TGF-β1 significantly increased to 85% immediately after AIT (20.13 ± 12 ng/mL, p < 0.05), to 95% 1 month after AIT (21.2 ± 11 ng/mL, p < 0.01), and to 105% 3 months after AIT (22.25 ± 16 ng/mL, p < 0.01) compared to before AIT (10.85 ± 8 ng/mL). Results also revealed that behavioral rating scales (CARS, SRS, and SSP) improved in terms of disease severity after AIT.
Increased plasma levels of TGF-β1 support the therapeutic effect of AIT on TGF-β1 followed by improvement in social awareness, social cognition, and social communication in children with ASD. Furthermore, TGF-β1 was associated with severity in all scores tested (CARS, SRS, and SSP); if confirmed in studies with larger sample sizes, TGF-β1 may be considered as a marker of ASD severity and to assess the efficacy of therapeutic interventions.
探讨听觉整合训练(AIT)对转化生长因子(TGF)-β1炎症生物标志物的影响,并评估其对自闭症谱系障碍(ASD)儿童社会行为的影响。
在这项横断面研究中,共招募了 15 名(男 14 名,女 1 名)年龄在 3-12 岁的 ASD 患者。所有患者均使用《精神障碍诊断与统计手册》(DSM-IV)进行自闭症筛查。所有患者均采用夹心酶联免疫吸附试验(ELISA)立即检测,并在 AIT 治疗后 1 个月和 3 个月检测 TGF-β1 的血浆水平。采用儿童自闭症评定量表(CARS)、社会反应量表(SRS)和短感觉量表(SSP)对每位儿童进行治疗前后的行为评分。数据分析采用社会科学统计软件包(SPSS 21.0 for Windows)。
AIT 后即刻,TGF-β1 血浆水平显著升高至 85%(20.13±12ng/ml,p<0.05),1 个月时升高至 95%(21.2±11ng/ml,p<0.01),3 个月时升高至 105%(22.25±16ng/ml,p<0.01),与 AIT 前相比(10.85±8ng/ml)。结果还显示,AIT 后疾病严重程度的行为评定量表(CARS、SRS 和 SSP)有所改善。
TGF-β1 血浆水平升高支持 AIT 对 TGF-β1 的治疗作用,随后 ASD 儿童的社会意识、社会认知和社会交往能力得到改善。此外,TGF-β1 与所有测试评分(CARS、SRS 和 SSP)的严重程度相关;如果在更大样本量的研究中得到证实,TGF-β1 可能被视为 ASD 严重程度的标志物,并评估治疗干预的疗效。